UnitedHealth Group Forms Public Responsibility Committee, Names Lead Director

UnitedHealth Group has established a new Public Responsibility Committee to enhance governance by overseeing financial, regulatory, and reputational risks, reflecting the company's commitment to responsibility and integrity. Michele Hooper will chair this committee, with members including Charles Baker, Timothy Flynn, and Paul Garcia, and the committee will coordinate with other board committees on risk oversight. The company also appointed F. William McNabb as the new lead independent director, replacing Hooper in that role, while she remains a board member. This move follows recent challenges faced by UnitedHealth, including a cut in its earnings forecast and a CEO replacement, as the company seeks to repair its standing with shareholders, regulators, and the public. Wall Street analysts rate UnitedHealth's stock as 'Outperform,' with a one-year price target averaging $328.08 and a projected upside of over 130% according to GuruFocus valuations. These changes underscore UnitedHealth’s focus on strengthening board oversight and risk management amid evolving market conditions.